logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Thomas, Robert James, Dr
    Born in June 1979
    Individual (5 offsprings)
    Officer
    icon of calendar 2016-06-01 ~ now
    OF - Director → CIF 0
    Dr Robert James Thomas
    Born in June 1979
    Individual (5 offsprings)
    Person with significant control
    icon of calendar 2016-06-01 ~ now
    PE - Right to appoint or remove directorsCIF 0
    PE - Ownership of shares – More than 50% but less than 75%CIF 0
    PE - Ownership of voting rights - More than 50% but less than 75%CIF 0
  • 2
    Glen, Katie Elizabeth, Dr
    Born in December 1978
    Individual (1 offspring)
    Officer
    icon of calendar 2020-06-01 ~ now
    OF - Director → CIF 0
    Dr Katie Elizabeth Glen
    Born in December 1978
    Individual (1 offspring)
    Person with significant control
    icon of calendar 2022-06-15 ~ now
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
Ceased 1
parent relation
Company in focus

ADVANCED BIOPROCESS SERVICES LIMITED

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Property, Plant & Equipment
97,455 GBP2024-03-31
162,873 GBP2023-03-31
Fixed Assets - Investments
4,992,976 GBP2024-03-31
3,577,915 GBP2023-03-31
Fixed Assets
5,090,431 GBP2024-03-31
3,740,788 GBP2023-03-31
Debtors
439,867 GBP2024-03-31
669,850 GBP2023-03-31
Cash at bank and in hand
480,773 GBP2024-03-31
293,296 GBP2023-03-31
Current Assets
920,640 GBP2024-03-31
963,146 GBP2023-03-31
Net Current Assets/Liabilities
693,343 GBP2024-03-31
710,775 GBP2023-03-31
Total Assets Less Current Liabilities
5,783,774 GBP2024-03-31
4,451,563 GBP2023-03-31
Net Assets/Liabilities
5,722,810 GBP2024-03-31
4,410,845 GBP2023-03-31
Equity
Called up share capital
1 GBP2024-03-31
1 GBP2023-03-31
Share premium
416,004 GBP2024-03-31
416,004 GBP2023-03-31
Retained earnings (accumulated losses)
5,306,805 GBP2024-03-31
3,994,840 GBP2023-03-31
Equity
5,722,810 GBP2024-03-31
4,410,845 GBP2023-03-31
Property, Plant & Equipment - Depreciation rate used
Plant and equipment
40 GBP2023-04-01 ~ 2024-03-31
Average Number of Employees
42023-04-01 ~ 2024-03-31
32022-07-01 ~ 2023-03-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
397,112 GBP2024-03-31
397,112 GBP2023-03-31
Property, Plant & Equipment - Gross Cost
397,112 GBP2024-03-31
397,112 GBP2023-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
299,657 GBP2024-03-31
234,239 GBP2023-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
299,657 GBP2024-03-31
234,239 GBP2023-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
65,418 GBP2023-04-01 ~ 2024-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
65,418 GBP2023-04-01 ~ 2024-03-31
Property, Plant & Equipment
Plant and equipment
97,455 GBP2024-03-31
162,873 GBP2023-03-31
Amounts invested in assets
Additions to investments, Non-current
1,333,937 GBP2024-03-31
Cost valuation, Non-current
4,992,976 GBP2024-03-31
Other Investments Other Than Loans
Non-current
4,992,976 GBP2024-03-31
3,577,915 GBP2023-03-31
Amounts invested in assets
Non-current
4,992,976 GBP2024-03-31
3,577,915 GBP2023-03-31
Trade Debtors/Trade Receivables
Amounts falling due within one year
20,208 GBP2024-03-31
224,934 GBP2023-03-31
Other Debtors
Amounts falling due within one year
1,200 GBP2023-03-31
Prepayments/Accrued Income
Amounts falling due within one year
3,655 GBP2024-03-31
27,712 GBP2023-03-31
Debtors
Amounts falling due within one year
439,867 GBP2024-03-31
669,850 GBP2023-03-31
Trade Creditors/Trade Payables
Amounts falling due within one year
18,833 GBP2024-03-31
28,381 GBP2023-03-31
Taxation/Social Security Payable
Amounts falling due within one year
203,824 GBP2024-03-31
220,060 GBP2023-03-31
Other Creditors
Amounts falling due within one year
365 GBP2024-03-31
356 GBP2023-03-31
Accrued Liabilities/Deferred Income
Amounts falling due within one year
4,275 GBP2024-03-31
3,574 GBP2023-03-31
Net Deferred Tax Liability/Asset
60,964 GBP2024-03-31
40,718 GBP2023-03-31

  • ADVANCED BIOPROCESS SERVICES LIMITED
    Info
    Registered number 10208462
    icon of address90 Main Street, East Leake, Loughborough, Leicestershire LE12 6PG
    PRIVATE LIMITED COMPANY incorporated on 2016-06-01 (9 years 6 months). The company status is Active.
    The last date of confirmation statement was made at 2024-11-15
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.